De Troyer A, Borenstein S, Cordier R
Thorax. 1980 Aug;35(8):603-10. doi: 10.1136/thx.35.8.603.
We investigated pulmonary mechanics in 25 patients, 9 to 55 years of age, with a variety of generalised neuromuscular diseases and variable degrees of respiratory muscle weakness. The average degree of inspiratory muscle force was 39.2% (range 8-83%) of predicted. The lung volume restriction far exceeded that expected for the degree of muscle weakness: the observed decrement in respiratory muscle force should, theoretically, decrease vital capacity to 78% of its control value, while the mean VC in our patients was only 50% of predicted. Analysis of lung pressure-volume curves indicated that the two principal causes of the disproportionate loss of lung volume were a reduction in lung distensibility probably caused by widespread microatelectasis, and a decrease in the outward pull of the chest wall. Because it reflects both direct (loss of distending pressure) and secondary (alterations in the elastic properties of the lungs and chest wall) effects of respiratory muscle weakness on lung function, we conclude that, in these patients, the vital capacity remains the most useful measurement to follow evolution of the disease process or response to treatment.
我们对25名年龄在9至55岁之间、患有各种全身性神经肌肉疾病且呼吸肌无力程度各异的患者进行了肺力学研究。吸气肌力的平均程度为预测值的39.2%(范围为8 - 83%)。肺容积受限程度远远超过了根据肌无力程度所预期的水平:理论上,观察到的呼吸肌力下降应使肺活量降至其对照值的78%,而我们患者的平均肺活量仅为预测值的50%。肺压力 - 容积曲线分析表明,肺容积不成比例减少的两个主要原因是可能由广泛微小肺不张导致的肺扩张性降低,以及胸壁向外牵引力的减小。由于肺活量既反映了呼吸肌无力对肺功能的直接影响(扩张压力丧失),也反映了间接影响(肺和胸壁弹性特性的改变),我们得出结论,在这些患者中,肺活量仍然是跟踪疾病进程演变或治疗反应的最有用指标。